• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


0.057 EUR 0.010 21.28%

As of 02:08:25 ET on 12/22/2014.

Snapshot for Karo Bio AB (KA6)

Open: 0.057 Day's Range: 0.057 - 0.057 Volume: 0
Previous Close: 0.047 52wk Range: 0.040 - 0.181 1-Yr Rtn: +18.75%

Stock Chart for KA6

No chart data available.
  • KA6:GR 0.057
  • 1M
  • 1Y
Interactive KA6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KA6

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) -0.0100
Est. PEG Ratio -
Market Cap (M EUR) 38.55
Shares Outstanding (M) 676.26
30 Day Average Volume 33
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KA6

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KA6

Karo Bio AB operates a drug research and development company. The Company develops precision drugs to treat major diseases in the field of nuclear receptors. Karo Bio works within many therapeutic areas including men and women's health, cardiovascular diseases, metabolic disorders and dermatology.

Per BengtssonPresident/CEOHenrik PalmChief Financial Officer
Maria SjoebergVP/Chief Scientific OfficerMark FarmeryHead:Business Development
More Company Profile & Key Executives for KA6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil